Bio-Rad Laboratories, Inc.
BIO institutional ownership changes in Q2 2026: 80 institutions opened or added positions, 101 trimmed or exited. BIO (Bio-Rad Laboratories, Inc.) is held by 183 institutional investors as of Q2 2026. Top institutional shareholders: First Eagle Investment Management, LLC ($765.2M), BlackRock, Inc. ($498.8M), Dimensional Fund Advisors LP ($277.3M). Net institutional sentiment: Mixed.
Who's Trading
Latest move
Source dates: Price Nov 5, 2026 · Insiders none · Activists Oct 30, 2025 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 2.6M(+0.1%) | $765.2M | 1.3% | +47.37% | 50 | |
Increased | 1.7M(+1.1%) | $498.8M | 0.0% | +12.44% | 32 | |
Decreased | 944,548(-13.3%) | $277.3M | 0.1% | +23.31% | 0 | |
Decreased | 826,972(-0.5%) | $242.8M | 0.0% | +34.50% | 0 | |
Increased | 816,751(+3.9%) | $239.8M | 2.4% | +24.36% | 55 | |
Decreased | 816,198(-1.6%) | $239.6M | 0.0% | +34.50% | 0 | |
Decreased | 580,752(-1.4%) | $170.5M | 0.6% | +1.55% | 0 | |
Increased | 571,762(+2.2%) | $167.9M | 0.0% | -2.26% | 31 | |
Increased | 490,412(+10.2%) | $144M | 0.0% | -0.06% | 33 | |
Increased | 462,457(+2.8%) | $135.8M | 0.0% | +34.30% | 31 | |
Increased | 443,483(+15.0%) | $130.2M | 0.0% | +31.48% | 35 | |
Decreased | 418,884(-1.7%) | $123M | 0.0% | +31.91% | 0 | |
Decreased | 347,575(-4.7%) | $102.1M | 0.0% | +3.99% | 0 | |
Increased | 328,897(+51.3%) | $96.6M | 0.1% | +32.11% | 50 | |
Decreased | 308,325(-13.0%) | $90.5M | 0.0% | +33.66% | 0 | |
Decreased | 273,377(-5.0%) | $80.3M | 0.1% | -10.42% | 0 | |
Decreased | 267,634(-4.0%) | $78.6M | 0.0% | +32.14% | 0 | |
Increased | 233,227(+57.8%) | $68.5M | 0.1% | +3.40% | 42 | |
Decreased | 218,285(-0.1%) | $64.1M | 0.0% | +7.78% | 0 | |
Decreased | 195,538(-0.5%) | $57.4M | 0.0% | +12.65% | 0 |
Showing 1-20 of 197
BIOBio-Rad Laboratories, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about BIO
Who owns BIO?
183 institutional investors held BIO on June 30, 2026, led by First Eagle Investment Management, LLC ($765.2M), BlackRock, Inc. ($498.8M) and Dimensional Fund Advisors LP ($277.3M).
How many hedge funds hold BIO?
183 institutional investors reported BIO in their 13F filings for the quarter ended June 30, 2026, $5B in all. 8 of them are rated Elite.
Are institutions buying or selling BIO?
Selling, on balance. In Q2 2026, 101 institutions trimmed or exited BIO and 80 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer